Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Greten

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Minerva Endocrinologica|April 14, 2010
Molecular therapy of pancreatic cancerR R Plentz, M P Manns, T F Greten
Gut|April 16, 2005
Hepatocellular carcinoma occurring after successful treatment of childhood cancer with high dose chemotherapy and radiationT F Greten, M P Manns, I Reinisch, et al.
Zeitschrift Fur Gastroenterologie|January 7, 2006
[Treatment of hepatocellular carcinoma]T F Greten, H E Blum, M P Manns, et al.
European Journal of Pharmacology|March 28, 1996
Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-alpha synthesisT F Greten, B Sinha, C Haslberger, et al.
European Journal of Gastroenterology & Hepatology|July 1, 1996
Synthesis of tumour necrosis factor-alpha in tissue culture of rat caecum: lack of suppression by phosphodiesterase inhibitors and prostanoidsT F Greten, J Moeller, H Feldmeier, et al.
British Journal of Cancer|November 20, 2008
Molecular therapy for the treatment of hepatocellular carcinomaT F Greten, F Korangy, M P Manns, et al.
International Journal of Immunopharmacology|July 1, 1995
The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-alpha and nitric oxideT F Greten, A Eigler, B Sinha, et al.
Current Protocols in Immunology|April 25, 2008
Monitoring antigen-specific T cells using MHC-Ig dimersJ P Schneck, J E Slansky, S M O'Herrin, et al.
Human Gene Therapy|May 15, 1998
Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccineM C Thomas, T F Greten, D M Pardoll, et al.
Deutsche Medizinische Wochenschrift (1946)|October 17, 2008
[Suspicion of a newly appearing hypertrophic obstructive cardiomyopathy in a patient treated for hepatocellular carcinoma]S Ciesek, T Kirchhoff, M Niehaus, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Minerva Endocrinologica|April 14, 2010
Molecular therapy of pancreatic cancerR R Plentz, M P Manns, T F Greten
Gut|April 16, 2005
Hepatocellular carcinoma occurring after successful treatment of childhood cancer with high dose chemotherapy and radiationT F Greten, M P Manns, I Reinisch, et al.
Zeitschrift Fur Gastroenterologie|January 7, 2006
[Treatment of hepatocellular carcinoma]T F Greten, H E Blum, M P Manns, et al.
European Journal of Pharmacology|March 28, 1996
Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-alpha synthesisT F Greten, B Sinha, C Haslberger, et al.
European Journal of Gastroenterology & Hepatology|July 1, 1996
Synthesis of tumour necrosis factor-alpha in tissue culture of rat caecum: lack of suppression by phosphodiesterase inhibitors and prostanoidsT F Greten, J Moeller, H Feldmeier, et al.
British Journal of Cancer|November 20, 2008
Molecular therapy for the treatment of hepatocellular carcinomaT F Greten, F Korangy, M P Manns, et al.
International Journal of Immunopharmacology|July 1, 1995
The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-alpha and nitric oxideT F Greten, A Eigler, B Sinha, et al.
Current Protocols in Immunology|April 25, 2008
Monitoring antigen-specific T cells using MHC-Ig dimersJ P Schneck, J E Slansky, S M O'Herrin, et al.
Human Gene Therapy|May 15, 1998
Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccineM C Thomas, T F Greten, D M Pardoll, et al.
Deutsche Medizinische Wochenschrift (1946)|October 17, 2008
[Suspicion of a newly appearing hypertrophic obstructive cardiomyopathy in a patient treated for hepatocellular carcinoma]S Ciesek, T Kirchhoff, M Niehaus, et al.
Pageof 5